The store will not work correctly when cookies are disabled.
2-(3-chlorophenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one
ID: ALA1091765
PubChem CID: 6187657
Max Phase: Preclinical
Molecular Formula: C15H9ClN2O2
Molecular Weight: 284.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1OC(c2cccc(Cl)c2)=N/C1=C\c1cccnc1
Standard InChI: InChI=1S/C15H9ClN2O2/c16-12-5-1-4-11(8-12)14-18-13(15(19)20-14)7-10-3-2-6-17-9-10/h1-9H/b13-7-
Standard InChI Key: JECOGJJTAAXRQA-QPEQYQDCSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
13.6792 -22.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6446 -23.1227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3421 -23.5641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0747 -23.1801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1054 -22.3502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4072 -21.9124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4381 -21.0880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1676 -20.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8393 -21.1881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5050 -20.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2440 -19.9160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4191 -19.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9313 -19.2558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3262 -20.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7323 -21.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5565 -21.4279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9756 -20.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5645 -19.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7417 -19.9925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9628 -22.1458 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
5 6 2 0
9 10 2 0
10 11 1 0
11 12 1 0
12 8 1 0
6 1 1 0
12 13 2 0
1 2 2 0
6 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
7 8 2 0
16 17 2 0
8 9 1 0
17 18 1 0
18 19 2 0
19 14 1 0
10 14 1 0
4 5 1 0
16 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.70 | Molecular Weight (Monoisotopic): 284.0353 | AlogP: 3.08 | #Rotatable Bonds: 2 |
Polar Surface Area: 51.55 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.68 | CX LogP: 3.23 | CX LogD: 3.23 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.63 | Np Likeness Score: -1.69 |
References
1. Okamoto M, Takayama K, Shimizu T, Muroya A, Furuya T.. (2010) Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening., 18 (7): [PMID:20206532] [10.1016/j.bmc.2010.02.018] |